Growth Metrics

Idexx Laboratories (IDXX) Share-based Compensation (2016 - 2026)

Idexx Laboratories has reported Share-based Compensation over the past 17 years, most recently at $16.1 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 13.0% year-over-year to $16.1 million; the TTM value through Dec 2025 reached $60.0 million, changed 0.47%, while the annual FY2025 figure was $60.0 million, 0.47% changed from the prior year.
  • Share-based Compensation for Q4 2025 was $16.1 million at Idexx Laboratories, up from $14.4 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $16.1 million in Q4 2025 and troughed at $8.9 million in Q1 2021.
  • A 5-year average of $13.4 million and a median of $14.3 million in 2024 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 36.71% in 2022 and later dropped 9.33% in 2025.
  • Year by year, Share-based Compensation stood at $9.7 million in 2021, then skyrocketed by 36.71% to $13.3 million in 2022, then grew by 14.64% to $15.2 million in 2023, then decreased by 6.34% to $14.3 million in 2024, then increased by 13.0% to $16.1 million in 2025.
  • Business Quant data shows Share-based Compensation for IDXX at $16.1 million in Q4 2025, $14.4 million in Q3 2025, and $14.9 million in Q2 2025.